Research

HIQA publishes reviews on the duration of immunity following COVID-19 vaccination

HIQA has today published three reviews on the duration of immunity following COVID-19 vaccination to inform the work of the NIAC.

HIQA older people ionising

The Health Information and Quality Authority (HIQA) has today published three reviews on the duration of immunity following COVID-19 vaccination. It is to inform the work of the National Immunisation Advisory Committee (NIAC).

HIQA reviewed international evidence assessing the duration of protective immunity following COVID-19 vaccination in the general population and specific subgroups. The initial review examined the duration of protective immunity following COVID-19 vaccination in all populations aged 12 years and older. The first update focused on healthcare workers, while the second update focused on individuals with underlying conditions.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free